# [Launching a Medical Device in the U.S. in 2026](/blog-posts/us-fda-foreign-manufacturer-launch-sequence-ace-import-workpaper-2026)

![Editorial illustration for the U.S. medical device launch workpaper.](https://www.pureglobal.com/assets/generated/blog-covers/rsc_sjv8zd6mq5jv43m8kpbzfkk2t0/en-5448d75b079e74a7.webp)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

Work through FDA pathway selection, registration, U.S. Agent and importer roles, QMSR readiness, and customs entry with two worked examples.

[

Read full story

](https://www.pureglobal.com/blog-posts/us-fda-foreign-manufacturer-launch-sequence-ace-import-workpaper-2026)

## Latest Articles

Items shown: 71

[![Editorial illustration for the U.S. medical device launch workpaper.](https://www.pureglobal.com/assets/generated/blog-covers/rsc_sjv8zd6mq5jv43m8kpbzfkk2t0/en-5448d75b079e74a7.webp)](https://www.pureglobal.com/blog-posts/us-fda-foreign-manufacturer-launch-sequence-ace-import-workpaper-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [Launching a Medical Device in the U.S. in 2026](https://www.pureglobal.com/blog-posts/us-fda-foreign-manufacturer-launch-sequence-ace-import-workpaper-2026)

Work through FDA pathway selection, registration, U.S. Agent and importer roles, QMSR readiness, and customs entry with two worked examples.

[

Read full story

](https://www.pureglobal.com/blog-posts/us-fda-foreign-manufacturer-launch-sequence-ace-import-workpaper-2026)

United States

[![Conceptual illustration of separate device classification and evidence decisions across four markets.](https://www.pureglobal.com/assets/generated/blog-covers/rsc_d8ejm4v079a4tbrdnkqrs6n0tx/en-553a2a821416459b.webp)](https://www.pureglobal.com/blog-posts/apac-eu-us-device-classification-clinical-pathway-divergence-japan-vietnam-mdr-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [Device Classification and Clinical Evidence Across Four Markets in 2026](https://www.pureglobal.com/blog-posts/apac-eu-us-device-classification-clinical-pathway-divergence-japan-vietnam-mdr-2026)

Assess device classification and clinical-data pathways across Japan, Vietnam, the US and EU, with dated registration and cost evidence.

[

Read full story

](https://www.pureglobal.com/blog-posts/apac-eu-us-device-classification-clinical-pathway-divergence-japan-vietnam-mdr-2026)

United States

European Union

Japan

Vietnam

[![Conceptual illustration of a device change moving through separate local regulatory release decisions.](https://www.pureglobal.com/assets/generated/blog-covers/rsc_w0bpapxjpnjn6qn6hzt2hpnnp1/en-bcc5c5be978694ec.webp)](https://www.pureglobal.com/blog-posts/apac-latam-post-approval-device-change-control-singapore-malaysia-hongkong-mexico-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [Device Change Control: A Five-Market Release Plan for 2026](https://www.pureglobal.com/blog-posts/apac-latam-post-approval-device-change-control-singapore-malaysia-hongkong-mexico-2026)

Classify device changes in five markets, identify local release conditions, and separate annual representation fees from government charges.

[

Read full story

](https://www.pureglobal.com/blog-posts/apac-latam-post-approval-device-change-control-singapore-malaysia-hongkong-mexico-2026)

Singapore

Malaysia

Hong Kong

Australia

Mexico

[![FDA 510(k) Pathway Selection: Evidence, Review Clocks and Costs in 2026](https://www.pureglobal.com/assets/generated/blog-covers/rsc_gch6xjx8rmdpssq2ckv5xnsmq5/en-b3937af3d17f1320.webp)](https://www.pureglobal.com/blog-posts/us-fda-510k-pathway-selection-3p510k-estar-review-clocks-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [FDA 510(k) Pathway Selection: Evidence, Review Clocks and Costs in 2026](https://www.pureglobal.com/blog-posts/us-fda-510k-pathway-selection-3p510k-estar-review-clocks-2026)

A data-backed guide to Traditional, Special, Abbreviated and third-party 510(k) decisions, with clear limits on what historical clearance times can predict.

[

Read full story

](https://www.pureglobal.com/blog-posts/us-fda-510k-pathway-selection-3p510k-estar-review-clocks-2026)

United States

[![Team-NB MDR Documentation: Submission Completeness Checks (2026)](https://www.pureglobal.com/assets/generated/blog-covers/rsc_3tsgpnb6f5zdpfb4m7sazs3dzf/en-ab0a139680571b18.webp)](https://www.pureglobal.com/blog-posts/team-nb-mdr-technical-documentation-completeness-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [Team-NB MDR Documentation: Submission Completeness Checks (2026)](https://www.pureglobal.com/blog-posts/team-nb-mdr-technical-documentation-completeness-2026)

Interpret Team-NB’s notified-body completeness survey correctly and turn MDR technical-documentation guidance into a scoped evidence and submission check.

[

Read full story

](https://www.pureglobal.com/blog-posts/team-nb-mdr-technical-documentation-completeness-2026)

European Union

[![21 CFR Part 820 to ISO 13485 crosswalk title on a Pure Global cover with a blue gradient background](https://www.pureglobal.com/assets/generated/blog-covers/rsc_h0ftq8nyfjatqb1h9t312bg1qj/en-be78161d57598769.webp)](https://www.pureglobal.com/blog-posts/fda-21-cfr-part-820-to-iso-13485-qmsr-crosswalk-guide)

### [21 CFR Part 820 to ISO 13485: The QMSR Crosswalk](https://www.pureglobal.com/blog-posts/fda-21-cfr-part-820-to-iso-13485-qmsr-crosswalk-guide)

QMSR cut 21 CFR Part 820 from 31 sections to six and made ISO 13485:2016 the rule. This crosswalk maps every old section to its ISO 13485 clause, marks which mappings FDA stated, lists the FDA-only requirements and shows where a decade of 483 citations now lands.

[

Read full story

](https://www.pureglobal.com/blog-posts/fda-21-cfr-part-820-to-iso-13485-qmsr-crosswalk-guide)

United States

[![FDA Cleared vs Approved vs Granted title on a Pure Global cover with a blue gradient background](https://www.pureglobal.com/assets/generated/blog-covers/rsc_5x46hr90zdc5p488c2rdxvvdhc/en-7c7fcda9c0d68554.webp)](https://www.pureglobal.com/blog-posts/fda-cleared-vs-approved-vs-granted-510k-pma-de-novo)

### [FDA Cleared vs Approved vs Granted: 510(k), PMA and De Novo](https://www.pureglobal.com/blog-posts/fda-cleared-vs-approved-vs-granted-510k-pma-de-novo)

In 2025 FDA cleared 3,198 devices through 510(k), granted 27 De Novo requests and approved 38 original PMAs. This guide explains what each word means legally, how long each route takes, what it costs in FY2027 and how to describe your device's status without misbranding it.

[

Read full story

](https://www.pureglobal.com/blog-posts/fda-cleared-vs-approved-vs-granted-510k-pma-de-novo)

United States

[![FDA Inspection Readiness Checklist title on a Pure Global cover with a blue gradient background](https://www.pureglobal.com/assets/generated/blog-covers/rsc_t44j6vys0xbzb74g6yv511evhj/en-6f2e3581aaef0ba1.webp)](https://www.pureglobal.com/blog-posts/fda-inspection-readiness-checklist-for-medical-device-manufacturers)

### [FDA Inspection Readiness Checklist (QMSR)](https://www.pureglobal.com/blog-posts/fda-inspection-readiness-checklist-for-medical-device-manufacturers)

FDA now inspects device makers under the QMSR and Compliance Program 7382.850. Our analysis of ten years of FDA Form 483 data shows where investigators find problems, and the 12-point checklist turns those findings into records to prepare before the investigator arrives.

[

Read full story

](https://www.pureglobal.com/blog-posts/fda-inspection-readiness-checklist-for-medical-device-manufacturers)

United States

[![FDA Medical Device Classification title on a Pure Global cover with a blue gradient background](https://www.pureglobal.com/assets/generated/blog-covers/rsc_wpxc2s4qsc91mkhysqhs4gmrhc/en-74735bd25e12a762.webp)](https://www.pureglobal.com/blog-posts/fda-medical-device-classification-class-i-ii-iii-guide)

### [FDA Medical Device Classification: Class I, II and III Explained](https://www.pureglobal.com/blog-posts/fda-medical-device-classification-class-i-ii-iii-guide)

FDA's October 2026 product code file puts 36.5% of classified codes in Class I, 55.4% in Class II and 8.0% in Class III. This guide explains what each class requires, why class alone does not decide the pathway, and how to confirm your device's class in six steps.

[

Read full story

](https://www.pureglobal.com/blog-posts/fda-medical-device-classification-class-i-ii-iii-guide)

United States

[![SaMD vs SiMD software as a medical device title on a Pure Global cover with a blue gradient background](https://www.pureglobal.com/assets/generated/blog-covers/rsc_4r5c86q3qj6gc6abqyrmzcjhrf/en-79623ffc1be6ec12.webp)](https://www.pureglobal.com/blog-posts/samd-software-as-a-medical-device-fda-eu-mdr-guide)

### [SaMD vs SiMD: Software as a Medical Device under FDA and EU MDR](https://www.pureglobal.com/blog-posts/samd-software-as-a-medical-device-fda-eu-mdr-guide)

Software as a Medical Device performs a medical purpose on its own; software in a medical device drives hardware. This guide explains how the difference changes classification under FDA and EU MDR Rule 11, what a submission needs in 2026 and what FDA's list of 1,614 AI-enabled devices shows.

[

Read full story

](https://www.pureglobal.com/blog-posts/samd-software-as-a-medical-device-fda-eu-mdr-guide)

United States

European Union

[![EUDAMED Registration Deadlines for Devices and Certificates in 2026](https://www.pureglobal.com/assets/generated/blog-covers/rsc_2ty278cdw8n27sh4szr3sbn89q/en-0f596db20d86f2b2.webp)](https://www.pureglobal.com/blog-posts/eudamed-registration-clocks-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [EUDAMED Registration Deadlines for Devices and Certificates in 2026](https://www.pureglobal.com/blog-posts/eudamed-registration-clocks-2026)

Separate mandatory use, device-registration backlog and certificate deadlines before judging an EUDAMED record or planning the next submission.

[

Read full story

](https://www.pureglobal.com/blog-posts/eudamed-registration-clocks-2026)

European Union

[![China GMP inspections: outsourcing registrants from November 2026](https://www.pureglobal.com/assets/generated/blog-covers/rsc_rvwrk3aav6nenrsrt224cevmk0/en-3aa330c361f9e368.webp)](https://www.pureglobal.com/blog-posts/china-gmp-outsourcing-inspection-checklist-november-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [China GMP inspections: outsourcing registrants from November 2026](https://www.pureglobal.com/blog-posts/china-gmp-outsourcing-inspection-checklist-november-2026)

Prepare for 1 November 2026 with a verified comparison of the registrant’s and manufacturer’s minimum inspection chapters, graded requirements and release responsibilities.

[

Read full story

](https://www.pureglobal.com/blog-posts/china-gmp-outsourcing-inspection-checklist-november-2026)

China

[![QMSR Warning Letters 2026 title on a Pure Global cover with a blue gradient background](https://www.pureglobal.com/assets/generated/blog-covers/rsc_yq2j0swkvw4n66xzz0fr1z4fns/en-0ce049dfabd1cb0d.webp)](https://www.pureglobal.com/blog-posts/qmsr-warning-letters-iso-13485-records-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [QMSR Warning Letters 2026: The ISO 13485 Records FDA Named](https://www.pureglobal.com/blog-posts/qmsr-warning-letters-iso-13485-records-2026)

Four posted FDA warning letters cite ISO 13485:2016 Clause 7.1 and name the missing records. Pull those first, then management-review and audit reports.

[

Read full story

](https://www.pureglobal.com/blog-posts/qmsr-warning-letters-iso-13485-records-2026)

United States

[![Evidence map connecting a device risk assessment to controls, verification, release and post-market review.](https://www.pureglobal.com/assets/generated/blog-covers/rsc_a1xmngch2terwtehv44t51jey1/en-466a8c7bc4ba73c2.webp)](https://www.pureglobal.com/blog-posts/iso-14971-risk-management-file-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [ISO 14971 Risk Files: Evidence and Review](https://www.pureglobal.com/blog-posts/iso-14971-risk-management-file-2026)

Use recall data, regulatory sources and worked examples to review risk controls and the evidence supporting release.

[

Read full story

](https://www.pureglobal.com/blog-posts/iso-14971-risk-management-file-2026)

United States

European Union

[![Decision map for representative appointments, registration ownership and transfer documents across global markets.](https://www.pureglobal.com/assets/generated/blog-covers/rsc_hkgkhr3a7scnbcjbyk4m12bzxa/en-5e10fec64e8d0956.webp)](https://www.pureglobal.com/blog-posts/in-country-representative-registration-holder-decision-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [In-Country Representatives and Registration Holders: 2026 Guide](https://www.pureglobal.com/blog-posts/in-country-representative-registration-holder-decision-2026)

Who holds the file matters when a distributor changes. Compare local roles, handover documents, transfer conditions and the full annual cost before appointing a partner.

[

Read full story

](https://www.pureglobal.com/blog-posts/in-country-representative-registration-holder-decision-2026)

No items found.

[![UDI work order connecting device identifiers, packaging, actors and regulatory records across the US, EU and China.](https://www.pureglobal.com/assets/generated/blog-covers/rsc_7sjaz5mjgvsh9vamsmkpbfafqm/en-b3595fa847c8228f.webp)](https://www.pureglobal.com/blog-posts/udi-us-eu-china-compliance-workorder-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [One Device, Three UDI Databases (2026): Build the US, EU and China Work Order](https://www.pureglobal.com/blog-posts/udi-us-eu-china-compliance-workorder-2026)

Shared identifiers need separate regulatory mappings. Use corrected database evidence, product-specific calendars and a scoped cost breakdown to plan the work.

[

Read full story

](https://www.pureglobal.com/blog-posts/udi-us-eu-china-compliance-workorder-2026)

United States

European Union

China

Switzerland

United Kingdom

[![Medical device technical file cost model comparing internal, outsourced, and hybrid routes](https://www.pureglobal.com/assets/generated/blog-covers/rsc_3p8y5hg8mhx0cfnj6vqtmn49at/en-87fa40185e63f5ec.webp)](https://www.pureglobal.com/blog-posts/medical-device-technical-file-compilation-cost-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [Medical Device Technical File Compilation Cost (2026): Build, Buy, or Hybrid?](https://www.pureglobal.com/blog-posts/medical-device-technical-file-compilation-cost-2026)

Technical-file quotes are incomparable until scope, writing, gap closure, reviewer responses, lifecycle maintenance, and authority fees are separated. This report combines public price lines, FDA workload data, EU survey evidence, and a break-even model to show when to build internally, buy a project, or use a hybrid team.

[

Read full story

](https://www.pureglobal.com/blog-posts/medical-device-technical-file-compilation-cost-2026)

United States

European Union

[![A global medical-device registration verification workpaper comparing public register rows, identity fields, and certificate records.](https://www.pureglobal.com/assets/generated/blog-covers/rsc_rkgax0bhe5ym9vgmtbpxtpfn57/en-9079ebce4294b284.webp)](https://www.pureglobal.com/blog-posts/medical-device-registration-verification-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [Medical Device Registration Verification 2026: What 15 National Public Data Files Actually Contain](https://www.pureglobal.com/blog-posts/medical-device-registration-verification-2026)

A public register is not a market map. This workpaper names what one row means, which identity fields are filled, and where verification still needs in-country evidence.

[

Read full story

](https://www.pureglobal.com/blog-posts/medical-device-registration-verification-2026)

United States

European Union

Singapore

Malaysia

Indonesia

UAE

Israel

Bangladesh

Brazil

Mexico

Argentina

Colombia

Australia

Canada

South Korea

Japan

[![Coronary Stent Global Market Access 2026 — Pure Global research report cover](https://www.pureglobal.com/assets/generated/blog-covers/rsc_jb9rmgp8dv42crwjqvbw2v87kz/en-a53bea73f82e4ef1.webp)](https://www.pureglobal.com/blog-posts/coronary-stent-global-market-access-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [Coronary Stent Global Market Access 2026: Class III Almost Everywhere](https://www.pureglobal.com/blog-posts/coronary-stent-global-market-access-2026)

Coronary stents sit at the highest regulatory tier across major markets. This report maps four US regulatory objects, the PMA supplement lifecycle, eight market-access files, public register evidence, postmarket limits, government fees and a sequencing plan for manufacturers.

[

Read full story

](https://www.pureglobal.com/blog-posts/coronary-stent-global-market-access-2026)

United States

European Union

United Kingdom

Canada

Australia

Japan

Singapore

Brazil

[![Surgical Robot Global Market Access 2026 — Pure Global research report cover](https://www.pureglobal.com/assets/generated/blog-covers/rsc_dzmysjwnm3ft0685kv2wxgaqnb/en-1c55f7acc9690797.webp)](https://www.pureglobal.com/blog-posts/surgical-robot-global-market-access-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [Surgical Robot Global Market Access 2026: One Platform, Eight Regulatory Files](https://www.pureglobal.com/blog-posts/surgical-robot-global-market-access-2026)

Surgical robots do not follow one regulatory class or one reusable filing. This research report maps the public records across eight markets, showing how architecture drives FDA classification, why one platform becomes dozens of registration objects, where clinical evidence controls the schedule, and what government and in-country representation fees actually cost.

[

Read full story

](https://www.pureglobal.com/blog-posts/surgical-robot-global-market-access-2026)

United States

European Union

United Kingdom

Canada

Australia

Japan

Singapore

Brazil

[![ISO 10993-1:2025 global transition guide — Pure Global cover on a blue gradient background](https://www.pureglobal.com/assets/generated/blog-covers/rsc_7psf7k5qy29sgvga6nr69zwhk8/en-762069f3290000cd.webp)](https://www.pureglobal.com/blog-posts/iso-10993-1-2025-global-transition-guide)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [ISO 10993-1:2025 Global Transition Guide: How to Build One Biological Evaluation Plan for Seven Regulatory Systems](https://www.pureglobal.com/blog-posts/iso-10993-1-2025-global-transition-guide)

ISO 10993-1 changed in 2025, but regulators did not change together. This practical guide maps seven regulatory systems and shows how to build one controlled biological-evaluation core with market-specific overlays.

[

Read full story

](https://www.pureglobal.com/blog-posts/iso-10993-1-2025-global-transition-guide)

United States

European Union

United Kingdom

Canada

Australia

Japan

China

[![IVD Global Market Access 2026 — Pure Global cover on a blue gradient background](https://www.pureglobal.com/assets/generated/blog-covers/rsc_amgpn24mseqt9k6bbanzvdp439/en-9490fdf3e9c5d26e.webp)](https://www.pureglobal.com/blog-posts/ivd-global-market-access-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [In Vitro Diagnostics Global Market Access 2026: The Year the Rules Moved in Opposite Directions](https://www.pureglobal.com/blog-posts/ivd-global-market-access-2026)

The EU inverted its IVD regime and the US reverted its own. This report rebuilds what that means for classification, timelines and cost from the registers themselves — including 238 IVDR certificates against 3,343 for devices, and the risk-class split across nine national registers.

[

Read full story

](https://www.pureglobal.com/blog-posts/ivd-global-market-access-2026)

United States

European Union

China

Brazil

South Korea

Singapore

Taiwan

Colombia

Saudi Arabia

Australia

[![Orthopedic Implant Global Market Access 2026 — Pure Global cover on a blue gradient background](https://www.pureglobal.com/assets/generated/blog-covers/rsc_n13q7wd5gvaqmsjbe2ekr0sgnj/en-2ef541df8b2177a6.webp)](https://www.pureglobal.com/blog-posts/orthopedic-implant-global-market-access-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [Orthopedic Implant Global Market Access 2026: One Implant, Seven Risk Classes — Registration Pathways, Timelines, Fees, and the Two Forces Reshaping Entry](https://www.pureglobal.com/blog-posts/orthopedic-implant-global-market-access-2026)

The same orthopedic implant can be Class II in the United States and Class III across the European Union, China, Japan and Australia. This report compares pathways, realistic timelines, government fees, reliance limits and mandatory in-country-representative costs across seven major markets.

[

Read full story

](https://www.pureglobal.com/blog-posts/orthopedic-implant-global-market-access-2026)

United States

European Union

China

South Korea

Brazil

Japan

Australia

[![Aesthetic Device Global Market Access 2026 — Pure Global cover on a blue gradient background](https://www.pureglobal.com/assets/generated/blog-covers/rsc_37j6rsdgkc997fgy5hr6f987fq/en-f89360ffd75452fb.webp)](https://www.pureglobal.com/blog-posts/aesthetic-device-global-market-access-2026)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [Aesthetic Device Global Market Access 2026: Registration Pathways, Timelines & Fees for Injectables and Energy-Based Devices](https://www.pureglobal.com/blog-posts/aesthetic-device-global-market-access-2026)

The same aesthetic device can face a different risk class, evidence burden and registration route in every major market. This research report compares fillers and energy-based platforms across the United States, European Union, China, Korea, Brazil and Japan — including realistic timelines, regulator fees, reliance routes and mandatory in-country-representative costs.

[

Read full story

](https://www.pureglobal.com/blog-posts/aesthetic-device-global-market-access-2026)

United States

European Union

China

South Korea

Brazil

Japan

Hong Kong

[![How to register medical devices and IVDs in Brazil](https://www.pureglobal.com/assets/owned/52eeb888b9--67ab304f89cb5422fdc63bec__687e7240130e91c146ef8ca2_samuel-costa-melo-RJz9Xmro1Fc-unsplash.jpg)](https://www.pureglobal.com/blog-posts/how-to-register-medical-devices-and-ivds-in-brazil)

### [How to register medical devices and IVDs in Brazil](https://www.pureglobal.com/blog-posts/how-to-register-medical-devices-and-ivds-in-brazil)

Registering a medical device or IVD in Brazil means navigating ANVISA's dual pathways—faster Notification for low-risk Class I/II devices, or rigorous Registration for higher-risk Class III/IV devices requiring B-GMP certification and technical dossiers. This guide walks through classification, appointing a Brazil Registration Holder, securing necessary certifications (INMETRO, ANATEL, INCQS), and meeting new UDI labeling requirements. It also covers the AREE reliance pathway, which lets manufacturers with existing FDA, TGA, Health Canada, or MHLW approvals potentially cut review times by 30%.

[

Read full story

](https://www.pureglobal.com/blog-posts/how-to-register-medical-devices-and-ivds-in-brazil)

Brazil

[![Continuous Glucose Monitors: The Global Map of Regulation, Registration, and Market Access — Pure Global](https://www.pureglobal.com/assets/generated/blog-covers/rsc_81gb3aeshcmea2qsma9yptz61x/en-c5bdaf5a3455b8f8.webp)](https://www.pureglobal.com/blog-posts/research-report-continuous-glucose-monitors-global-market-access)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [Continuous Glucose Monitors: The Global Map of Regulation, Registration, and Market Access](https://www.pureglobal.com/blog-posts/research-report-continuous-glucose-monitors-global-market-access)

The continuous glucose monitor is the fastest-scaling category in diabetes technology, and in 2024 it broke out of diabetes entirely — onto pharmacy shelves as an over-the-counter wellness product. Yet the same sensor is Class II in the U.S. (now sold OTC), Class IIb in the EU, and Class III in China. This report maps how every major regulator classifies, approves, and reimburses CGM — and why a single FDA clearance or CE mark clears none of the three gates (approval, reimbursement, intellectual property) by itself — with registration costs, timelines, and reliance routes across 30+ markets.

[

Read full story

](https://www.pureglobal.com/blog-posts/research-report-continuous-glucose-monitors-global-market-access)

United States

European Union

China

Japan

Singapore

Brazil

[![AI as a Medical Device: The Global Map of Regulation, Registration, and Market Access — Pure Global](https://www.pureglobal.com/assets/generated/blog-covers/rsc_ajx4q86s7zkkchyw4p7nemzmj8/en-0b9690e6d7bd76b7.webp)](https://www.pureglobal.com/blog-posts/research-report-ai-as-a-medical-device-global-market-access)

[

Deep Research

](https://www.pureglobal.com/resources/blog?tag=deep-research)

### [AI as a Medical Device: The Global Map of Regulation, Registration, and Market Access](https://www.pureglobal.com/blog-posts/research-report-ai-as-a-medical-device-global-market-access)

Artificial intelligence is the fastest-growing class of medical device in history — and the most regulation-divergent. The U.S. FDA now lists 1,524 AI-enabled devices; South Korea authorized 153 in a single year. Yet the same software is Class II in the U.S., Class IIa+ and 'high-risk' in the EU, and Class III in China — each with its own evidence, local-holder, and change-control rules. This report maps how every major regulator classifies, approves, and polices AI as a medical device, with registration costs, timelines, and reliance routes across 30+ markets, and the playbook for reaching them without rebuilding the dossier each time.

[

Read full story

](https://www.pureglobal.com/blog-posts/research-report-ai-as-a-medical-device-global-market-access)

United States

European Union

China

Japan

Singapore

Brazil

[![How to register medical devices and IVDs in Mexico](https://www.pureglobal.com/assets/owned/bcdf1a67a7--67ab304f89cb5422fdc63bec__68a62f0ac24c11da1bcf2113_robbie-herrera-lDjxXumgpT8-unsplash.jpg)](https://www.pureglobal.com/blog-posts/how-to-register-medical-devices-and-ivds-in-mexico)

### [How to register medical devices and IVDs in Mexico](https://www.pureglobal.com/blog-posts/how-to-register-medical-devices-and-ivds-in-mexico)

Since September 2025, COFEPRIS's new Abbreviated Pathway has opened a faster, more accessible route to market for manufacturers who already hold approvals from major regulatory bodies like the FDA, CE, Health Canada, and others. Instead of navigating a lengthy full technical review, you can now leverage your existing approvals to dramatically cut submission time and complexity. This guide breaks down everything you need to know — from eligibility requirements and device classification to documentation, timelines, and how to appoint a Mexico Registration Holder.

[

Read full story

](https://www.pureglobal.com/blog-posts/how-to-register-medical-devices-and-ivds-in-mexico)

Mexico

[![How to use your FDA and EU medical device approvals to access 25+ markets](https://www.pureglobal.com/assets/owned/d28f222102--67ab304f89cb5422fdc63bec__6a19f60d5f1722ed84cd54f3_paws_and_prints-lURELJ9C_xA-unsplash-1-.jpg)](https://www.pureglobal.com/blog-posts/how-to-use-your-fda-and-eu-medical-device-approvals-to-access-25-markets)

### [How to use your FDA and EU medical device approvals to access 25+ markets](https://www.pureglobal.com/blog-posts/how-to-use-your-fda-and-eu-medical-device-approvals-to-access-25-markets)

Your medical device and IVD approvals in the US and EU can streamline pathways in 25+ markets worldwide, from Australia and Switzerland to Brazil and Singapore, cutting the time and cost of international expansion. And with AI-powered tools now helping regulatory specialists build submissions up to 50% faster, scaling your device portfolio across borders has never been more achievable.

[

Read full story

](https://www.pureglobal.com/blog-posts/how-to-use-your-fda-and-eu-medical-device-approvals-to-access-25-markets)

United States

European Union

Brazil

Mexico

Switzerland

Singapore

Malaysia

Thailand

Australia

Canada

Taiwan

Hong Kong

Israel

India

United Kingdom

Colombia

UAE

[![How to register medical devices and IVDs in Australia](https://www.pureglobal.com/assets/owned/31be896e4d0599b2.jpg)](https://www.pureglobal.com/blog-posts/australia-tga-medical-device-artg-registration-guide)

### [How to register medical devices and IVDs in Australia](https://www.pureglobal.com/blog-posts/australia-tga-medical-device-artg-registration-guide)

Australia is a highly attractive market for medical device manufacturers, but gaining access requires navigating the TGA's rigorous registration process. This step-by-step guide covers the full pathway to ARTG inclusion, from device classification and Sponsor obligations through to Manufacturer Evidence, application submission, and audit preparation, with practical guidance on costs and timelines.

[

Read full story

](https://www.pureglobal.com/blog-posts/australia-tga-medical-device-artg-registration-guide)

No items found.

[![ANVISA’s International Cooperation and Regulatory Convergence Are Reshaping Brazil's Medical Device Market](https://www.pureglobal.com/assets/owned/185bd701a7--67ab304f89cb5422fdc63bec__68e93de98d323dc62d947b83_samuel-costa-melo-RJz9Xmro1Fc-unsplash-min.jpg)](https://www.pureglobal.com/blog-posts/anvisas-international-cooperation-and-regulatory-convergence-are-reshaping-brazils-medical-device-market)

### [ANVISA’s International Cooperation and Regulatory Convergence Are Reshaping Brazil's Medical Device Market](https://www.pureglobal.com/blog-posts/anvisas-international-cooperation-and-regulatory-convergence-are-reshaping-brazils-medical-device-market)

Brazil's health regulator is moving fast, strengthening international alliances and overhauling key rules for medical devices, software, and post-market surveillance. Learn how ANVISA's 2026–2027 priorities will affect your registration strategy.

[

Read full story

](https://www.pureglobal.com/blog-posts/anvisas-international-cooperation-and-regulatory-convergence-are-reshaping-brazils-medical-device-market)

Brazil

[![Christ the Redeemer statue in Rio de Janeiro, Brazil at sunset.](https://www.pureglobal.com/assets/owned/cf01285ab80d2614.jpg)](https://www.pureglobal.com/blog-posts/brazil-medical-device-market-statistics)

### [40+ Statistics About Brazil’s Medical Device Import Market Manufacturers Need to Know](https://www.pureglobal.com/blog-posts/brazil-medical-device-market-statistics)

Brazil is the largest medical device import market in Latin America, and it's growing faster than it was three years ago. But the countries winning share, the clinical specialties leading growth, and the risks manufacturers need to plan for have all shifted meaningfully since 2021. This article compiles 40+ statistics from Pure Global's four-year import analysis to show what the data actually says.

[

Read full story

](https://www.pureglobal.com/blog-posts/brazil-medical-device-market-statistics)

Brazil

[![Indonesia's Medical Device and IVD Import Market](https://www.pureglobal.com/assets/owned/e07a355471--67ab304f89cb5422fdc63bec__690adb04a3a2c6f5b259f1bd_indonesia-medtech-import-market-002.png)](https://www.pureglobal.com/blog-posts/indonesias-medical-device-and-ivd-import-market)

### [Indonesia's Medical Device and IVD Import Market](https://www.pureglobal.com/blog-posts/indonesias-medical-device-and-ivd-import-market)

Indonesia's $3.28 Billion MedTech Import Market Reset: The IVD Bubble Is Over; The Surgical Boom Has Begun. The report emphasizes that the 2024 boom was not a simple recovery but a fundamental shift in market demand. The growth was overwhelmingly powered by specialties related to elective and high-acuity procedures, reflecting a move to clear surgical backlogs and a long-term government strategy to improve domestic hospital capabilities.

[

Read full story

](https://www.pureglobal.com/blog-posts/indonesias-medical-device-and-ivd-import-market)

Indonesia

[![Leveraging Medical Device CE Marking for Faster Entry into Brazil](https://www.pureglobal.com/assets/owned/185bd701a7--67ab304f89cb5422fdc63bec__68e93de98d323dc62d947b83_samuel-costa-melo-RJz9Xmro1Fc-unsplash-min.jpg)](https://www.pureglobal.com/blog-posts/leveraging-medical-device-ce-marking-for-faster-entry-into-brazil)

### [Leveraging Medical Device CE Marking for Faster Entry into Brazil](https://www.pureglobal.com/blog-posts/leveraging-medical-device-ce-marking-for-faster-entry-into-brazil)

Medical device manufacturers sometimes shy away from Brazil as a potential market due to its cumbersome and meticulous regulatory requirements. But if you already have CE Marking, ANVISA approval is more accessible than you think. Learn how ANVISA requirements overlap with the EU MDR.

[

Read full story

](https://www.pureglobal.com/blog-posts/leveraging-medical-device-ce-marking-for-faster-entry-into-brazil)

Brazil

European Union

[![Smart phone calculator on a desk with a laptop and paperwork.](https://www.pureglobal.com/assets/owned/885ba1872c--67ab304f89cb5422fdc63bec__68d2c0e1b35b411a97a45e66_jakub-zerdzicki-heiYgqp0Tsk-unsplash.jpg)](https://www.pureglobal.com/blog-posts/medical-device-registration-costs-and-timelines-for-brazil-mexico-and-colombia)

### [Medical Device Registration Costs and Timelines for Brazil, Mexico, and Colombia](https://www.pureglobal.com/blog-posts/medical-device-registration-costs-and-timelines-for-brazil-mexico-and-colombia)

Expanding into Brazil, Mexico, and Colombia can be a major growth driver if you understand the true costs and timelines involved. This guide shows much it costs and how long approvals really take.

[

Read full story

](https://www.pureglobal.com/blog-posts/medical-device-registration-costs-and-timelines-for-brazil-mexico-and-colombia)

Colombia

Brazil

Mexico

[![Thailand's Medical Device and IVD Import Market](https://www.pureglobal.com/assets/owned/98c0a583f5--67ab304f89cb5422fdc63bec__68c99c98732436a22bd1d25e_thailand-medtech-import-market.002.png)](https://www.pureglobal.com/blog-posts/thailands-medical-device-and-ivd-import-market)

### [Thailand's Medical Device and IVD Import Market](https://www.pureglobal.com/blog-posts/thailands-medical-device-and-ivd-import-market)

Thailand's $3.29 Billion MedTech Import Market Undergoes Radical Shift as Post-Pandemic Demand for Aesthetics and Elder Care Surges, New Research Reveals. An analysis of historical data from 2021 to 2024 reveals an import-driven ecosystem with a total market value fluctuating between approximately $3.15 billion and $3.29 billion annually. This market is fundamentally sustained by two long-term drivers: a rapidly aging population and a thriving medical tourism sector, both of which are amplified by the government's strategic goal to establish the nation as a global "Medical Hub."

[

Read full story

](https://www.pureglobal.com/blog-posts/thailands-medical-device-and-ivd-import-market)

Thailand

[![Brazil's Medical Device and IVD Import Market](https://www.pureglobal.com/assets/owned/0aa1e5d740--67ab304f89cb5422fdc63bec__68bebf0c31792057c44a97f7_brazil-medical-device-import-market-research.002.png)](https://www.pureglobal.com/blog-posts/brazils-medical-device-and-ivd-import-market)

### [Brazil's Medical Device and IVD Import Market](https://www.pureglobal.com/blog-posts/brazils-medical-device-and-ivd-import-market)

Brazil's market for imported medical technology has demonstrated exceptional growth and a significant competitive realignment, establishing itself as a critical destination for global MedTech manufacturers. The total import market surged to USD $9.33 billion in 2024, an impressive 18.0% year-over-year increase, signaling a robust and accelerating demand for advanced healthcare solutions.

[

Read full story

](https://www.pureglobal.com/blog-posts/brazils-medical-device-and-ivd-import-market)

Brazil

[![Mexico city landmark with Mexico flag flying in the wind.](https://www.pureglobal.com/assets/owned/bcdf1a67a7--67ab304f89cb5422fdc63bec__68a62f0ac24c11da1bcf2113_robbie-herrera-lDjxXumgpT8-unsplash.jpg)](https://www.pureglobal.com/blog-posts/mexicos-abbreviated-regulatory-pathway-is-a-game-changer-for-medical-device-market-access)

### [Mexico’s Abbreviated Regulatory Pathway is a Game-Changer for Medical Device Market Access](https://www.pureglobal.com/blog-posts/mexicos-abbreviated-regulatory-pathway-is-a-game-changer-for-medical-device-market-access)

Mexico’s COFEPRIS will launch its new Abbreviated Regulatory Pathway on September 1, 2025, enabling medical device and drug manufacturers to fast-track approvals by leveraging prior authorizations from trusted international regulators. The streamlined process promises 30-day evaluations, aligning Mexico more closely with global regulatory standards and offering manufacturers a faster route to market.

[

Read full story

](https://www.pureglobal.com/blog-posts/mexicos-abbreviated-regulatory-pathway-is-a-game-changer-for-medical-device-market-access)

Mexico

[![Mexico's Medical Device and IVD Import Market](https://www.pureglobal.com/assets/owned/dddd5c71d0--67ab304f89cb5422fdc63bec__689d207da58cc38bcf6de56b_mexico-medical-device-import-market-research.005.png)](https://www.pureglobal.com/blog-posts/research-report-mexicos-medical-device-and-ivd-import-market)

### [Mexico's Medical Device and IVD Import Market](https://www.pureglobal.com/blog-posts/research-report-mexicos-medical-device-and-ivd-import-market)

Mexico's medical device and in-vitro diagnostic (IVD) import market is a dynamic and rapidly expanding landscape, presenting both significant opportunities and complex challenges for global manufacturers. An analysis of historical import data from 2021 to 2024 reveals a market characterized by robust overall growth, shifting competitive dynamics among global trade partners, and transformative regulatory reforms. The total value of medical device and in-vitro diagnostic (IVD) imports to Mexico surged from $6.86 billion in 2021 to $11.40 billion in 2024, marking a 12.6% increase in the final year alone.

[

Read full story

](https://www.pureglobal.com/blog-posts/research-report-mexicos-medical-device-and-ivd-import-market)

Mexico

[![Malaysia's Medical Device and IVD Market](https://www.pureglobal.com/assets/owned/a994efc0f1--67ab304f89cb5422fdc63bec__68868ef7b9363c11d1ae4037_malaysia-medical-device-ivd-market.003.png)](https://www.pureglobal.com/blog-posts/research-report-malaysias-medical-device-and-ivd-market)

### [Malaysia's Medical Device and IVD Market](https://www.pureglobal.com/blog-posts/research-report-malaysias-medical-device-and-ivd-market)

The Malaysian medical device and in-vitro diagnostic (IVD) market presents a compelling, high-growth opportunity, projected to reach US$4.5 billion by 2028 with a robust compound annual growth rate (CAGR) of approximately 9%. This expansion is underpinned by strong economic fundamentals, a consistent increase in government healthcare spending—highlighted by a 10% budget increase for 2025—and a clear national strategy to modernize the healthcare sector.

[

Read full story

](https://www.pureglobal.com/blog-posts/research-report-malaysias-medical-device-and-ivd-market)

Malaysia

[![A patient is taking a COVID test with part of the test displayed on a tabletop.](https://www.pureglobal.com/assets/owned/ffca11a000--67ab304f89cb5422fdc63bec__687e7823a4fd69a4cbeccfa1_annie-spratt-PXZEg4hnyVw-unsplash-min.jpg)](https://www.pureglobal.com/blog-posts/mdcg-2025-5-clarifies-eu-rules-for-ivd-performance-studies-under-ivdr)

### [MDCG 2025-5 Clarifies EU Rules for IVD Performance Studies Under IVDR](https://www.pureglobal.com/blog-posts/mdcg-2025-5-clarifies-eu-rules-for-ivd-performance-studies-under-ivdr)

Dr. Oliver Eikenberg breaks down the European Commission’s new MDCG 2025-5 guidance on IVD performance studies under the IVDR. He highlights how the document clarifies when studies require ethics and authority submissions, what qualifies as a substantial modification, and how to ensure data quality and compliance. For manufacturers and sponsors preparing for CE marking, these insights are essential to avoid costly delays and rejections.

[

Read full story

](https://www.pureglobal.com/blog-posts/mdcg-2025-5-clarifies-eu-rules-for-ivd-performance-studies-under-ivdr)

European Union

[![Brazil flag waves in the wind](https://www.pureglobal.com/assets/owned/52eeb888b9--67ab304f89cb5422fdc63bec__687e7240130e91c146ef8ca2_samuel-costa-melo-RJz9Xmro1Fc-unsplash.jpg)](https://www.pureglobal.com/blog-posts/brazils-udi-system-nears-enforcement-what-medical-device-manufacturers-must-know-for-2025-and-beyond)

### [Brazil’s UDI System Nears Enforcement: What Medical Device Manufacturers Must Know for 2025 and Beyond](https://www.pureglobal.com/blog-posts/brazils-udi-system-nears-enforcement-what-medical-device-manufacturers-must-know-for-2025-and-beyond)

Brazil’s Unique Device Identification (UDI) system is moving toward full enforcement, with mandatory labeling for Class IV devices starting July 10, 2025. This post breaks down the key requirements under RDC 591/2021 and RDC 884/2024, including SIUD database functions, labeling rules, and preparation steps for manufacturers.

[

Read full story

](https://www.pureglobal.com/blog-posts/brazils-udi-system-nears-enforcement-what-medical-device-manufacturers-must-know-for-2025-and-beyond)

Brazil

[![ASEAN MedTech Import Market](https://www.pureglobal.com/assets/owned/5253a14477--67ab304f89cb5422fdc63bec__68866fcb6582e0a0327b8c94_asean-medtech-import-market.004.png)](https://www.pureglobal.com/blog-posts/research-report-asean-medtech-import-market)

### [ASEAN MedTech Import Market](https://www.pureglobal.com/blog-posts/research-report-asean-medtech-import-market)

Exploring the profound opportunities and increasing complexity in the Association of South-East Asian Nations medical technology import market from 2021-2024. The ASEAN MedTech import market presents significant opportunities amid increasing complexity. Analysis of export data from 2021-2024 reveals robust growth drivers despite top-line volatility. While demographic and economic trends signal sustained demand, aggregate import value fluctuated from $19.16 billion in 2021 to $18.34 billion in 2022, $17.79 billion in 2023, before rebounding to $19.26 billion in 2024.

[

Read full story

](https://www.pureglobal.com/blog-posts/research-report-asean-medtech-import-market)

Singapore

China

India

[![Hands typing on a laptop keyboard](https://www.pureglobal.com/assets/owned/22fea4a18d--67ab304f89cb5422fdc63bec__686fd8eccd3fc08cff32f09b_glenn-carstens-peters-npxXWgQ33ZQ-unsplash.jpg)](https://www.pureglobal.com/blog-posts/5-reasons-eu-device-manufacturers-should-register-in-eudamed-today)

### [5 Reasons EU device manufacturers should register in EUDAMED today](https://www.pureglobal.com/blog-posts/5-reasons-eu-device-manufacturers-should-register-in-eudamed-today)

The European Commission has confirmed that key EUDAMED modules will become mandatory by Q3 2026 and manufacturers selling into the EU need to be ready. This article outlines five key reasons to prioritize EUDAMED registration now to avoid disruption, ensure compliance, and maintain market access.

[

Read full story

](https://www.pureglobal.com/blog-posts/5-reasons-eu-device-manufacturers-should-register-in-eudamed-today)

European Union

[![Singapore device registration expedites access to other markets.](https://www.pureglobal.com/assets/owned/d72b058cfe--67ab304f89cb5422fdc63bec__6851c2cb4ecab4320dc29153_Singapore.jpg)](https://www.pureglobal.com/blog-posts/singapore-hsa-as-a-gateway-to-faster-device-registration-in-key-markets)

### [Singapore HSA as a Gateway to Faster Device Registration in Key Markets](https://www.pureglobal.com/blog-posts/singapore-hsa-as-a-gateway-to-faster-device-registration-in-key-markets)

Singapore’s Health Sciences Authority (HSA) is now a globally recognized reference agency, offering manufacturers a fast track into key Asia-Pacific markets. This article explains how HSA approval can streamline registration in Thailand, Australia, and Hong Kong, and how its WHO Stringent Regulatory Authority status boosts access for high-risk IVDs. Leveraging HSA can cut costs, reduce timelines, and accelerate international expansion.

[

Read full story

](https://www.pureglobal.com/blog-posts/singapore-hsa-as-a-gateway-to-faster-device-registration-in-key-markets)

Singapore

[![A patient adjusts a medical device smart watch.](https://www.pureglobal.com/assets/owned/46e07315e0--67ab304f89cb5422fdc63bec__68029f482e5b8f3cea4ea33d_isens-usa-lB9arVo7v50-unsplash.jpg)](https://www.pureglobal.com/blog-posts/wireless-compliance-for-medical-device-manufacturers-overview-of-radio-frequency-module-integration)

### [Wireless Compliance for Medical Device Manufacturers: Overview of Radio Frequency Module Integration](https://www.pureglobal.com/blog-posts/wireless-compliance-for-medical-device-manufacturers-overview-of-radio-frequency-module-integration)

Manufacturers marketing a wireless medical device must consider communications authority regulations as well as medical device regulations. In this article, Michael Cassidy explains global market access requirements that manufacturers need to consider when integrating wireless module to their device.

[

Read full story

](https://www.pureglobal.com/blog-posts/wireless-compliance-for-medical-device-manufacturers-overview-of-radio-frequency-module-integration)

United States

European Union

[![A globe sits on top of a desk next to a business man working on this laptop.](https://www.pureglobal.com/assets/owned/19297d6e69--67ab304f89cb5422fdc63bec__67e57b48cad536bb91eb451a_67ab304f89cb5422fdc63f84_Untitled-design.webp)](https://www.pureglobal.com/blog-posts/how-the-eu-ivdr-opens-doors-beyond-the-eu)

### [How the EU IVDR opens doors beyond the EU](https://www.pureglobal.com/blog-posts/how-the-eu-ivdr-opens-doors-beyond-the-eu)

Under the IVDR, European CE Marking requires more time and resources from IVD manufacturers than ever before. However, as more countries adopt the EU's approach to medical device and IVD regulation, IVD companies will find themselves well positioned to access other markets beyond the EU once their IVDR CE Mark is in place. In this article, Dr. Oliver Eikenberg discusses the potential to leverage IVDR CE Marking to streamline global market access.

[

Read full story

](https://www.pureglobal.com/blog-posts/how-the-eu-ivdr-opens-doors-beyond-the-eu)

European Union

[![Supply chain controls for Economic Operators under the EU IVDR](https://www.pureglobal.com/assets/owned/9214750d76--67ab304f89cb5422fdc63bec__67dd6b0250b402b6eb312518_Graphics-for-Blog-7.png)](https://www.pureglobal.com/blog-posts/supply-chain-requirements-for-economic-operators-under-the-eu-ivdr)

### [Supply chain requirements for Economic Operators under the EU IVDR](https://www.pureglobal.com/blog-posts/supply-chain-requirements-for-economic-operators-under-the-eu-ivdr)

Inadequate supply chain controls are a leading cause of non-conformities in Notified Body Technical Documentation Assessments under the IVDR. In this article, Dr. Oliver Eikenberg discusses how manufacturers should assess and update their supply chain agreements to ensure Economic Operator roles and obligations are clearly defined in line with IVDR requirements.

[

Read full story

](https://www.pureglobal.com/blog-posts/supply-chain-requirements-for-economic-operators-under-the-eu-ivdr)

European Union

[![Clinical Evidence under IVDR: what is an “adequate level” for IVD manufacturers?](https://www.pureglobal.com/assets/owned/eee66e0698--67ab304f89cb5422fdc63bec__67d43d7bc11ba6eb789520c2_IVDR-BLOG-6-Graphics.png)](https://www.pureglobal.com/blog-posts/clinical-evidence-under-ivdr-what-is-an-adequate-level-for-ivd-manufacturers)

### [Clinical Evidence under IVDR: what is an “adequate level” for IVD manufacturers?](https://www.pureglobal.com/blog-posts/clinical-evidence-under-ivdr-what-is-an-adequate-level-for-ivd-manufacturers)

Conformity under the IVDR requires a rigorous approach to clinical evidence quality. In this article, Dr. Oliver Eikenberg explains the importance of performance evaluation processes and documentation to ensure adequate clinical evidence for EU IVDR compliance.

[

Read full story

](https://www.pureglobal.com/blog-posts/clinical-evidence-under-ivdr-what-is-an-adequate-level-for-ivd-manufacturers)

European Union

[![RIVM report: The impact of the new European IVD-classification rules on notified body involvement A study on IVDs registered in the Netherlands](https://www.pureglobal.com/assets/owned/6ef7d0c5a3b3b37e.png)](https://www.pureglobal.com/blog-posts/engaging-a-notified-body-under-the-ivdr-what-legacy-manufacturers-need-to-know-about-the-pre-application-process)

### [Engaging a Notified Body under the IVDR: What legacy manufacturers need to know about the pre-application process](https://www.pureglobal.com/blog-posts/engaging-a-notified-body-under-the-ivdr-what-legacy-manufacturers-need-to-know-about-the-pre-application-process)

The IVDR transition includes structured processes IVD manufacturers must follow to engage with Notified Bodies. Many IVD manufacturers are interacting with Notified Bodies for the first time and must understand what is required to ensure a successful partnership. In this article, Dr. Oliver Eikenberg clarifies what manufacturers must prepare and when to engage a Notified Body for IVDR CE Marking.

[

Read full story

](https://www.pureglobal.com/blog-posts/engaging-a-notified-body-under-the-ivdr-what-legacy-manufacturers-need-to-know-about-the-pre-application-process)

European Union

[![Regulatory requirements and challenges for new and old Class D devices under IVDR](https://www.pureglobal.com/assets/owned/3575d512ef908e3c.png)](https://www.pureglobal.com/blog-posts/regulatory-requirements-and-challenges-for-new-and-old-class-d-devices-under-ivdr)

### [Regulatory requirements and challenges for new and old Class D devices under IVDR](https://www.pureglobal.com/blog-posts/regulatory-requirements-and-challenges-for-new-and-old-class-d-devices-under-ivdr)

Class D IVD manufacturers face fast-approaching IVDR transition deadlines, though some are more familiar with the regulatory process. In this article, Dr. Oliver Eikenberg discusses the difference between "new" and "old" Class Ds, and regulatory logistics they need to consider during the transition process.

[

Read full story

](https://www.pureglobal.com/blog-posts/regulatory-requirements-and-challenges-for-new-and-old-class-d-devices-under-ivdr)

European Union

[![Intended purpose for IVDs and impact on the classification under IVDR](https://www.pureglobal.com/assets/owned/c6c036792a--67ab304f89cb5422fdc63bec__67c6fb5e70765599c76d5c67_67b6248e6f25e85d03d53d06_thumbnail_colombia-04.png)](https://www.pureglobal.com/blog-posts/intended-purpose-for-ivds-and-impact-on-the-classification-under-ivdr)

### [Intended purpose for IVDs and impact on the classification under IVDR](https://www.pureglobal.com/blog-posts/intended-purpose-for-ivds-and-impact-on-the-classification-under-ivdr)

Your IVD's intended purpose determines its classification, clinical evidence requirements, and clinical applications under the IVDR. Device companies will need a more robust intended purpose to fulfill IVDR criteria. In this article, Dr. Oliver Eikenberg explains the role of the intended purpose in IVDR compliance.

[

Read full story

](https://www.pureglobal.com/blog-posts/intended-purpose-for-ivds-and-impact-on-the-classification-under-ivdr)

European Union

[![Why and How EU IVDR Compliance Matters before the May 2025 Deadline](https://www.pureglobal.com/assets/owned/0770cc98e0--67ab304f89cb5422fdc63bec__67c6fb5eeca3b077370b504e_67b35d9632cc84d8a97e2504_4.png)](https://www.pureglobal.com/blog-posts/why-and-how-eu-ivdr-compliance-matters-before-the-may-2025-deadline)

### [Why and How EU IVDR Compliance Matters before the May 2025 Deadline](https://www.pureglobal.com/blog-posts/why-and-how-eu-ivdr-compliance-matters-before-the-may-2025-deadline)

Many IVD and legacy IVD device manufacturers are obligated to comply with certain aspects of the IVDR even before their transition deadline. In this article, Oliver Eikenberg discusses how IVD companies can maintain EU compliance during the transition period.

[

Read full story

](https://www.pureglobal.com/blog-posts/why-and-how-eu-ivdr-compliance-matters-before-the-may-2025-deadline)

European Union

[![Adapting your QMS to IVDR requirements until May 2025: what manufacturers need to know](https://www.pureglobal.com/assets/owned/1bafafa0ac--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63fc9_Finalized-IVDR-image.webp)](https://www.pureglobal.com/blog-posts/adapting-your-qms-to-ivdr-requirements-until-may-2025-what-manufacturers-need-to-know)

### [Adapting your QMS to IVDR requirements until May 2025: what manufacturers need to know](https://www.pureglobal.com/blog-posts/adapting-your-qms-to-ivdr-requirements-until-may-2025-what-manufacturers-need-to-know)

The official IVDR transition period is here. IVDR expert Dr. Oliver Eikenberg discusses how IVD manufacturers should take action, starting with how to implement IVDR QMS requirements for the May 2025 deadline.

[

Read full story

](https://www.pureglobal.com/blog-posts/adapting-your-qms-to-ivdr-requirements-until-may-2025-what-manufacturers-need-to-know)

No items found.

[![Kuala Lumpur Malaysia Skyline](https://www.pureglobal.com/assets/owned/8938ee59ea--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63f3b_Malaysia.webp)](https://www.pureglobal.com/blog-posts/mda-updates-at-imdec-2024-paving-the-way-for-regulatory-excellence-and-innovation-in-medical-technology)

### [MDA Updates at IMDEC 2024: Paving the Way for Regulatory Excellence and Innovation in Medical Technology](https://www.pureglobal.com/blog-posts/mda-updates-at-imdec-2024-paving-the-way-for-regulatory-excellence-and-innovation-in-medical-technology)

Pure Global participated in IMDEC 2024 in Kuala Lumpur to discuss the latest advancements in medical technology, regulatory efficiency, and the role of AI in transforming the industry. Highlights included updates from the Malaysian Medical Device Authority (MDA) that showcased their commitment to driving regional leadership in medical device regulation and innovation.

[

Read full story

](https://www.pureglobal.com/blog-posts/mda-updates-at-imdec-2024-paving-the-way-for-regulatory-excellence-and-innovation-in-medical-technology)

Malaysia

[![Pure Global 2024 Year in Review](https://www.pureglobal.com/assets/owned/57b672fbcc2c6eeb.webp)](https://www.pureglobal.com/blog-posts/pure-global-2024-a-year-of-growth-innovation-and-global-impact)

### [Pure Global 2024: A Year of Growth, Innovation, and Global Impact](https://www.pureglobal.com/blog-posts/pure-global-2024-a-year-of-growth-innovation-and-global-impact)

As 2024 comes to a close, Pure Global proudly reflects on a transformative year marked by substantial growth, cutting-edge innovation, and impactful collaborations.

[

Read full story

](https://www.pureglobal.com/blog-posts/pure-global-2024-a-year-of-growth-innovation-and-global-impact)

No items found.

[![Risk increases compliance chalenges under IVDR](https://www.pureglobal.com/assets/owned/d96211bbdb--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63fb6_6744dbd3f055107e208bf297_IVDR-Blog-Image.webp)](https://www.pureglobal.com/blog-posts/what-are-the-challenges-under-ivdr)

### [What are the challenges under IVDR?](https://www.pureglobal.com/blog-posts/what-are-the-challenges-under-ivdr)

IVD manufacturers cite the new classification system, detailed definitions for intended purposes, and the need for verification of clinical evidence as key challenges under the IVDR.

[

Read full story

](https://www.pureglobal.com/blog-posts/what-are-the-challenges-under-ivdr)

European Union

[![The EU Parliament votes on a resolution to revise specific parts of the MDR and IVDR](https://www.pureglobal.com/assets/owned/743972bdbf959acd.webp)](https://www.pureglobal.com/blog-posts/the-eu-parliament-votes-on-a-resolution-to-revise-specific-parts-of-the-mdr-and-ivdr)

### [The EU Parliament votes on a resolution to revise specific parts of the MDR and IVDR](https://www.pureglobal.com/blog-posts/the-eu-parliament-votes-on-a-resolution-to-revise-specific-parts-of-the-mdr-and-ivdr)

On October 23, the European Parliament adopted a resolution revising specific elements of the Medical Devices Regulation (MDR) and the In Vitro Diagnostic Devices Regulation (IVDR). This resolution intends to address ongoing challenges in implementing the regulations by 2025 and to improve patient access to important medical products.

[

Read full story

](https://www.pureglobal.com/blog-posts/the-eu-parliament-votes-on-a-resolution-to-revise-specific-parts-of-the-mdr-and-ivdr)

European Union

[![Transla.ai: Simplifying Multi-Language Documentation for Global MedTech Companies](https://www.pureglobal.com/assets/owned/628ec7cb2c--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63f93_Image-3.webp)](https://www.pureglobal.com/blog-posts/transla-ai-simplifying-multi-language-documentation-for-global-medtech-companies)

### [Transla.ai: Simplifying Multi-Language Documentation for Global MedTech Companies](https://www.pureglobal.com/blog-posts/transla-ai-simplifying-multi-language-documentation-for-global-medtech-companies)

Multilingual documentation presents ongoing compliance and logistical hurdles for MedTech manufacturers. Transla.Ai is an industry-specific translation tool that can accelerate and streamline the translation process.

[

Read full story

](https://www.pureglobal.com/blog-posts/transla-ai-simplifying-multi-language-documentation-for-global-medtech-companies)

No items found.

[![Changing Global Markets - Brazil: Navigating New Regulatory Landscapes](https://www.pureglobal.com/assets/owned/ab09da02fc--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63f88_Brazil-Blog-2-.webp)](https://www.pureglobal.com/blog-posts/changing-global-markets-brazil-navigating-new-regulatory-landscapes)

### [Changing Global Markets - Brazil: Navigating New Regulatory Landscapes](https://www.pureglobal.com/blog-posts/changing-global-markets-brazil-navigating-new-regulatory-landscapes)

Brazil aligns medical device regulations with global standards, including Europe and the US. Recent updates and international compatibility attract manufacturers.

[

Read full story

](https://www.pureglobal.com/blog-posts/changing-global-markets-brazil-navigating-new-regulatory-landscapes)

Brazil

[![The Impact of AI on Brazil's MedTech Sector](https://www.pureglobal.com/assets/owned/ee93cd900b--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63f87_impact-of-ai-in-medtech-.webp)](https://www.pureglobal.com/blog-posts/the-impact-of-ai-in-the-medtech-sector)

### [The Impact of AI on Brazil's MedTech Sector](https://www.pureglobal.com/blog-posts/the-impact-of-ai-in-the-medtech-sector)

AI is revolutionizing MedTech in Brazil, enhancing healthcare through process optimization and data-driven decisions. Pure Global ensures swift, compliant market introduction of innovative solutions.

[

Read full story

](https://www.pureglobal.com/blog-posts/the-impact-of-ai-in-the-medtech-sector)

Brazil

[![Pure Global: Regulatory Decisions for Global Success](https://www.pureglobal.com/assets/owned/c0f67fb4b0--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63f84_Untitled-design.webp)](https://www.pureglobal.com/blog-posts/pure-global-regulatory-decisions-for-global-success)

### [Pure Global: Regulatory Decisions for Global Success](https://www.pureglobal.com/blog-posts/pure-global-regulatory-decisions-for-global-success)

Discover how to navigate commercial and regulatory challenges for global success in the medical device industry. Learn strategies for market access, regulatory compliance, and post-market vigilance

[

Read full story

](https://www.pureglobal.com/blog-posts/pure-global-regulatory-decisions-for-global-success)

No items found.

[![New Standards in Med Dev Cybersecurity](https://www.pureglobal.com/assets/owned/c4f344bd54--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63f7a_blog_1.webp)](https://www.pureglobal.com/blog-posts/new-standards-in-medical-device-cybersecurity)

### [New Standards in Med Dev Cybersecurity](https://www.pureglobal.com/blog-posts/new-standards-in-medical-device-cybersecurity)

Raising cybersecurity standards for medical devices necessitates manufacturers' compliance with new global regulations.

[

Read full story

](https://www.pureglobal.com/blog-posts/new-standards-in-medical-device-cybersecurity)

United States

Australia

Singapore

[![Brazilian Markets Navigation: Pure Global Alliance](https://www.pureglobal.com/assets/owned/414513523c--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63f79_blog_2.webp)](https://www.pureglobal.com/blog-posts/navigating-brazilian-markets-a-strategic-alliance-with-pureglobal)

### [Brazilian Markets Navigation: Pure Global Alliance](https://www.pureglobal.com/blog-posts/navigating-brazilian-markets-a-strategic-alliance-with-pureglobal)

Brazil stands as Latin America's largest medical device market, regulated by ANVISA with recent updates to accommodate new technologies and international harmonization.

[

Read full story

](https://www.pureglobal.com/blog-posts/navigating-brazilian-markets-a-strategic-alliance-with-pureglobal)

Brazil

[![US Regulatory insights: Global Collaboration](https://www.pureglobal.com/assets/owned/6a5616d86c--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63f7d_blog_3.webp)](https://www.pureglobal.com/blog-posts/us-regulatory-insights-pure-global-collaboration)

### [US Regulatory insights: Global Collaboration](https://www.pureglobal.com/blog-posts/us-regulatory-insights-pure-global-collaboration)

Combining expert regulatory guidance with cutting-edge clinical laboratory support to streamline the FDA approval process.

[

Read full story

](https://www.pureglobal.com/blog-posts/us-regulatory-insights-pure-global-collaboration)

United States

[![Partnering with Pure Global Singapore](https://www.pureglobal.com/assets/owned/23e6dd4bdc--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63f7b_blog_4.webp)](https://www.pureglobal.com/blog-posts/partnering-with-pure-global-singapore)

### [Partnering with Pure Global Singapore](https://www.pureglobal.com/blog-posts/partnering-with-pure-global-singapore)

With a population of 5+ million, Singapore has the highest GDP per capita in Asia, according to Trading Economics.

[

Read full story

](https://www.pureglobal.com/blog-posts/partnering-with-pure-global-singapore)

Singapore

[![Decoding Health tech Regulations](https://www.pureglobal.com/assets/owned/3896ac5d3a--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63f80_blog_5.webp)](https://www.pureglobal.com/blog-posts/untangling-the-regulations-of-health-tech)

### [Decoding Health tech Regulations](https://www.pureglobal.com/blog-posts/untangling-the-regulations-of-health-tech)

Exploring the evolution from wellness apps to regulated medical devices, highlighting the significance of global compliance and security.

[

Read full story

](https://www.pureglobal.com/blog-posts/untangling-the-regulations-of-health-tech)

Australia

United States

[![Outsourced vs DIY Regulatory services: Perspectives](https://www.pureglobal.com/assets/owned/16cc116455--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63f7e_blog_8.webp)](https://www.pureglobal.com/blog-posts/perspectives-on-using-outsourced-regulatory-services-vs-the-diy-approach)

### [Outsourced vs DIY Regulatory services: Perspectives](https://www.pureglobal.com/blog-posts/perspectives-on-using-outsourced-regulatory-services-vs-the-diy-approach)

Addressing product development and regulatory hurdles, medical device and IVD manufacturers are advised to assess capabilities and seek external expertise for market success.

[

Read full story

](https://www.pureglobal.com/blog-posts/perspectives-on-using-outsourced-regulatory-services-vs-the-diy-approach)

European Union

[![Human Factors in Med Device Manufacturing](https://www.pureglobal.com/assets/owned/890ea5483c--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63f81_blog_6.webp)](https://www.pureglobal.com/blog-posts/human-factors-in-medical-device-manufacturing)

### [Human Factors in Med Device Manufacturing](https://www.pureglobal.com/blog-posts/human-factors-in-medical-device-manufacturing)

An overview of essential human factors engineering standards and guidance for global medical device manufacturers.

[

Read full story

](https://www.pureglobal.com/blog-posts/human-factors-in-medical-device-manufacturing)

China

European Union

United States

United Kingdom

Canada

[![Recall Management: Med dev Post-Market Duties](https://www.pureglobal.com/assets/owned/04413d5d87--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63f82_blog_9.webp)](https://www.pureglobal.com/blog-posts/recall-management-a-necessary-evil-of-a-medical-device-companys-post-market-responsibilities)

### [Recall Management: Med dev Post-Market Duties](https://www.pureglobal.com/blog-posts/recall-management-a-necessary-evil-of-a-medical-device-companys-post-market-responsibilities)

Navigating the complexities of medical device recalls requires a robust management plan and clear communication strategies.

[

Read full story

](https://www.pureglobal.com/blog-posts/recall-management-a-necessary-evil-of-a-medical-device-companys-post-market-responsibilities)

United States

European Union

Australia

United Kingdom

China

[![Unlocking Device Market Access: Reimbursement Essentials](https://www.pureglobal.com/assets/owned/09c8ac15bf--67ab304f89cb5422fdc63bec__67ab304f89cb5422fdc63f7f_blog_7.webp)](https://www.pureglobal.com/blog-posts/understanding-reimbursement-related-payment-is-a-critical-piece-of-medical-device-market-access-strategy)

### [Unlocking Device Market Access: Reimbursement Essentials](https://www.pureglobal.com/blog-posts/understanding-reimbursement-related-payment-is-a-critical-piece-of-medical-device-market-access-strategy)

A guide to regulatory clearances, global reimbursement strategies, and the essential PICO approach.

[

Read full story

](https://www.pureglobal.com/blog-posts/understanding-reimbursement-related-payment-is-a-critical-piece-of-medical-device-market-access-strategy)

United States

[Canonical page](https://www.pureglobal.com/resources/blog)
